Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naïve chronically infected patient
Open Access
- 26 January 2008
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 47 (2), 766-767
- https://doi.org/10.1002/hep.22122
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Low-Level K65R Mutation in HIV-1 Reverse Transcriptase of Treatment-Experienced Patients Exposed to Abacavir or DidanosineJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis CHepatology, 2007
- Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patientsHepatology, 2007
- Phenotypic and Structural Analyses of Hepatitis C Virus NS3 Protease Arg155 VariantsJournal of Biological Chemistry, 2007
- Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor TelaprevirGastroenterology, 2007
- Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genomeJournal of Clinical Virology, 2006
- SVARAP and aSVARAP: simple tools for quantitative analysis of nucleotide and amino acid variability and primer selection for clinical microbiologyBMC Microbiology, 2006